Genascence

Genascence

Verified
Developing revolutionized life changing gene therapies for prevalent musculoskeletal and joint diseases.

Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$42—63m (Dealroom.co estimates May 2022.)
Palo Alto California (HQ)
Authorizing premium user...